查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2012115

高强度聚焦超音波（HIFU）设备市场：导引、剂量方法、技术、产品、应用与终端用户－2026-2032年全球市场预测

High Intensity Focused Ultrasound Devices Market by Guidance, Delivery Mode, Technology, Product, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年，高强度聚焦超音波（HIFU）设备市值为30.9亿美元，预计2026年将达到34亿美元。以10.81%的复合年增长率计算，预计到2032年将达到63.5亿美元。

主要市场统计数据
基准年 2025 30.9亿美元
预计年份：2026年 34亿美元
预测年份 2032 63.5亿美元
复合年增长率 (%) 10.81%

高强度聚焦超音波（HIFU）设备正从实验平台发展成为跨多个学科领域的重要临床工具。本文透过检验临床需求、技术成熟度和监管变化之间的相互作用，概述了当前的生态系统。近年来，HIFU在非侵入性和微创工作流程中的有效性已引起临床医生的广泛关注。此外，设备形式的多样化也拓宽了其应用途径。这些趋势与日益复杂的医保报销环境交织在一起，积极的早期临床结果正在推动保险公司与医疗机构的合作以及医疗机构的投资决策。

临床应用的进展得益于多种因素的共同作用，包括影像引导技术的改进、操作流程的清晰化以及训练有素的操作人员数量的增加。同时，製造商也在不断改进设备的人体工学设计、能量传输方式以及与医院资讯系统的集成，以提升处理能力和易用性。主要市场的监管机构也在调整其审批流程以适应新的治疗方法，加上大量可靠证据的积累，这些因素共同加速了新疗法的临床应用。所有这些因素共同构成了一个充满活力的环境，在这个环境中，策略的清晰度、营运的准备程度以及证据的一致性将决定哪些相关人员能够从这项技术的未来潜力中持续受益。

转变聚焦超音波治疗的患者照护路径、报销框架、跨学科合作和技术环境。

在聚焦超音波治疗领域，一场变革正在发生，它正在改变临床路径、竞争动态以及支付方和医疗服务提供者的预期。导航系统和治疗计画软体的进步使得治疗过程更加可预测和可重复，这些技术进步也推动了后续训练模式和医院工作流程的变革。随着技术的普及应用，人们不仅要评估设备的有效性，还要评估其处理能力、治疗总成本以及与现有影像系统的互通性。

评估 2025 年美国关税对供应链、采购经济、合作和设备可用性的累积影响。

美国2025年实施的关税政策对整个聚焦超音波设备生态系统产生了累积影响，波及采购经济性、供应链设计和国际合作模式。由于进口零件和组件的关税增加，成本上升，设备製造商正在重新思考筹资策略，强调供应商多元化，并尽可能选择近岸外包。虽然这些供应链调整可以降低单一供应商中断的风险，但也增加了供应商认证和品管的过渡成本和复杂性。

细分洞察揭示了影像引导、传输方式、技术选择、产品类型、临床应用和最终用户环境对部署的影响。

对细分市场的深入理解揭示了临床、技术和商业性选择如何在不同环境中造成不同的部署模式。本分析考察了磁振造影（MRI）引导和超音波引导两种影像引导方法，这两种方法导致了不同的临床工作流程。 MRI导引手术可提供更优异的软组织视觉化和温度测量，但需要更高的资本投入和专用手术室。另一方面，超音波导引系统具有更广泛的临床应用和手术柔软性。治疗途径可分为体外、组织间和腔内三种，每种途径对应不同的临床团队、基础设施需求和病患选择标准。技术选择也是差异因素，机械消融与热消融相比，表现出不同的机械生物效应。即使在热消融方法中，连续波和脉衝波模式也具有不同的安全性、能量管理特性和手术计画要求。

区域性洞察，比较全球范围内的驱动因素、基础设施发展、监管方法、报销趋势和临床引入模式。

区域趋势在决定聚焦超音波技术的应用、推广和报销方面发挥着至关重要的作用。在美洲，领先的医疗中心和发展相对迅速的私人保险市场支持了针对特定适应症的早期临床应用。同时，强大的学术网络推动了多中心证据的累积。从早期采用者到医疗机构更广泛应用的转变需要临床倡议者和采购决策者之间的合作，而这项转变的时机往往取决于区域报销环境。

竞争对手在产品平臺、策略联盟、生产规模、监管进展和市场策略的趋势。

聚焦超音波领域的企业格局呈现出竞争、合作和策略专业并存的特征。主要企业正奉行两大策略：提升核心技术能力和建立伙伴关係，以扩大临床应用和服务范围。投资重点通常包括改进治疗计划软体、增强影像整合以及降低手术复杂性，旨在降低培训门槛并扩大设备的应用环境。尤其值得注意的是，随着设备从最初的临床应用过渡到医院的常规操作，生产规模和品管系统正日益成为企业竞争地位的关键因素。

为产业领导者提供策略建议，以加速临床部署、优化供应链、调整报销方式并优先考虑研发。

产业领导者应着重关注能够将策略意图转化为可衡量成果的可执行优先事项。首先，将研发蓝图与临床工作流程相契合，能够提升医疗设备的功能，进而降低手术复杂性，并解决临床医师面临的挑战。投资于以使用者为中心的设计和整合影像工作流程通常能够加速医疗机构的采纳。其次，透过供应商多元化、本地组装和模组化组件策略来增强供应链韧性，可以降低关税风险并减少前置作业时间波动。

严谨的调查方法，说明了主要和次要资料、专家访谈、检验程序、细分逻辑和分析方法。

本分析的调查方法遵循严谨的一手和二手研究证据收集、专家检验以及高度透明的细分逻辑。一手研究活动包括对临床意见领袖、采购负责人和技术主管进行结构化访谈，以了解他们对临床工作流程、推广障碍和采购优先事项的实际观点。二手研究则利用同侪审查文献、监管核准和公开资料，全面检验临床结果、设备特性和治疗路径的演变。

该分析整合了策略意义、新兴风险和机会，以及领导者应采取的可操作步骤，以了解超音波。

总而言之，高强度聚焦超音波（HIFU）市场环境兼具临床应用潜力与营运复杂性，需要采取严谨的策略行动。关键在于，要使设备功能与临床工作流程相契合，展现以患者为中心的清晰疗效，并以有意义的方式向采购和报销利益相关人员体现价值。新兴风险包括供应链中断、不同司法管辖区的监管差异，以及需要强有力的证据来获得更广泛支付方的支持。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 高强度聚焦超音波（HIFU）设备市场分类指南

  • 磁共振引导
  • 超音波引导

第九章 高强度聚焦超音波（HIFU）设备市场：以交付方式划分

  • 体外
  • 间质
  • 腔内

第十章 高强度聚焦超音波（HIFU）设备市场：依技术分类

  • 机械消融
  • 热消融
    • 连续波
    • 脉搏波

第十一章 高强度聚焦超音波（HIFU）设备市场：依产品分类

  • 可携式的
  • 固定式

第十二章 高强度聚焦超音波（HIFU）设备市场：依应用领域划分

  • 肝肿瘤
  • 胰臟肿瘤
  • 摄护腺癌
  • 子宫肌瘤

第十三章：高强度聚焦超音波（HIFU）设备市场：依最终用户划分

  • 门诊手术中心
  • 医院
  • 专科诊所

第十四章：高强度聚焦超音波（HIFU）设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：高强度聚焦超音波（HIFU）设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：高强度聚焦超音波（HIFU）设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 美国高强度聚焦超音波（HIFU）设备市场

第十八章 中国高强度聚焦超音波（HIFU）设备市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Alpinion Medical Systems Co., Ltd.
  • Chongqing Haifu Medical Technology Co., Ltd.
  • EDAP TMS SA
  • FEBIO GmbH
  • FUS Instruments Inc.
  • ILJIN Holdings Co., Ltd.
  • Image Guided Therapy SAS
  • Insightec Ltd.
  • Mianyang Sonic Electronic Ltd.
  • Profound Medical Corp.
  • Shenzhen Weixianke Electronics Co., Ltd.
  • SonaCare Medical LLC
  • Storz Medical AG
  • Theraclion
Product Code: MRR-43539E5D36FD

The High Intensity Focused Ultrasound Devices Market was valued at USD 3.09 billion in 2025 and is projected to grow to USD 3.40 billion in 2026, with a CAGR of 10.81%, reaching USD 6.35 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.09 billion
Estimated Year [2026] USD 3.40 billion
Forecast Year [2032] USD 6.35 billion
CAGR (%) 10.81%

High intensity focused ultrasound devices have moved from experimental platforms to influential clinical tools across multiple specialties, and this introduction frames the current ecosystem by examining the interplay of clinical need, technological maturity and regulatory evolution. Recent years have seen proof points in noninvasive and minimally invasive workflows that have accelerated clinician interest, while a more diverse set of device form factors has broadened pathways to adoption. These trends intersect with an increasingly complex reimbursement landscape, where early positive clinical outcomes are catalyzing payer engagement and institutional investment decisions.

Clinical momentum is supported by converging drivers: improved imaging guidance, clearer procedural protocols, and a growing cadre of trained operators. Concurrently, manufacturers are refining device ergonomics, energy delivery modalities and integration with hospital information systems to improve throughput and ease of use. Regulatory authorities in key markets have also adapted submission pathways to accommodate novel therapeutic modalities, which reduces time to clinical availability when paired with robust evidence generation. Taken together, these forces create a dynamic environment in which strategic clarity, operational readiness and evidence alignment will determine which stakeholders sustainably benefit from the technology's promise.

Transformations reshaping patient pathways, reimbursement frameworks, cross-disciplinary collaborations, and technological landscape in focused ultrasound therapies

The focused ultrasound landscape is undergoing transformative shifts that are altering clinical pathways, competitive dynamics and the expectations of payers and providers. Advances in guidance systems and treatment planning software are enabling more predictable, reproducible procedures, and this technical progress drives downstream changes in training models and hospital workflows. As adoption increases, devices are being evaluated not only on efficacy but also on throughput, total cost of procedure and interoperability with existing imaging suites.

In parallel, reimbursement frameworks are moving from experimental coverage toward more structured pathways in certain indications, shifting economic incentives and encouraging larger-scale deployments. Cross-disciplinary collaborations between radiology, oncology and surgical specialties are fostering hybrid care models that incorporate focused ultrasound as an adjunct or alternative to surgery or systemic therapy. Commercial strategies are responding with diversified go-to-market approaches that combine direct hospital partnerships, specialty clinic engagement and expanded service offerings. The outcome is a market that is more nuanced: success favors organizations that align R&D priorities with real-world clinical needs and that can demonstrate operational and economic value across a spectrum of care settings.

Assessment of the cumulative consequences of United States tariffs in 2025 on supply chains, procurement economics, collaboration and device accessibility

The introduction of United States tariffs in 2025 has produced cumulative effects across the focused ultrasound device ecosystem by influencing procurement economics, supply chain design and international collaboration patterns. Tariff-induced cost increases on imported components and subassemblies have prompted device manufacturers to re-evaluate sourcing strategies, emphasizing supplier diversification and nearshoring where feasible. These supply chain adaptations reduce exposure to single-source disruptions but also introduce transitional costs and complexity in vendor qualification and quality control.

Procurement teams at hospitals and specialty clinics have responded by tightening vendor evaluations and seeking clearer total-cost-of-ownership calculations, which now must account for tariff-inflated capital and consumable expenses. For companies that relied on long-standing cross-border manufacturing partnerships, tariffs have accelerated decisions to localize assembly or to renegotiate commercial terms with distributors. The regulatory and clinical trial landscape has also felt indirect effects: higher operational costs can slow enrollment incentives or increase the cost of running multi-center studies, which in turn affects evidence generation timelines.

Finally, the tariffs have incentivized more rigorous scenario planning among executives, who are balancing short-term margin protection tactics with longer-term investments in supply chain resilience and cost engineering. The net impact is a re-prioritization of strategic focus toward operational agility, supplier risk management and clearer communication of value to procurement stakeholders facing stretched capital budgets.

Segmentation insights revealing how imaging guidance, delivery mode, technology choice, product type, clinical application and end-user setting affect adoption

A nuanced understanding of segmentation reveals how clinical, technical and commercial choices drive differentiated adoption patterns across settings. This analysis considers imaging guidance across MRI Guided and Ultrasound Guided approaches, which create distinct clinical workflows: MRI-guided procedures offer superior soft-tissue visualization and thermometry yet demand higher capital intensity and specialized suites, while ultrasound-guided systems enable broader point-of-care use and procedural flexibility. Delivery mode is differentiated by Extracorporeal, Interstitial and Intracavitary approaches, and each mode aligns with different clinical teams, infrastructure requirements and patient selection criteria. Technology selection is another axis of variation, with Mechanical Ablation offering distinct mechanobiological effects compared with Thermal Ablation; within thermal approaches, the continuous wave and pulsed wave modalities present divergent safety profiles, energy management characteristics and procedural planning needs.

Product form factors range from Portable to Stationary devices, and that distinction has profound implications for deployment: portable systems facilitate ambulatory and outpatient settings, whereas stationary platforms are optimized for high-volume hospital suites with advanced imaging integration. Clinical applications-spanning Liver Tumor, Pancreatic Tumor, Prostate Cancer and Uterine Fibroids-each have unique evidence requirements, referral pathways and reimbursement considerations, and the pace of clinical adoption varies accordingly. End-user segmentation includes Ambulatory Surgical Centers, Hospitals and Specialty Clinics, and these settings differ in capital purchasing cycles, staffing models and procedural throughput expectations. Understanding how these segmentation axes intersect enables more targeted product development, evidence generation and commercialization strategies that match technology attributes to clinical and operational realities.

Regional insights comparing drivers, infrastructure readiness, regulatory approaches, reimbursement dynamics and clinical adoption patterns across world regions

Regional dynamics play a decisive role in shaping how focused ultrasound technologies are adopted, scaled and reimbursed. In the Americas, leading centers of excellence and a relatively fast-moving private payer market have supported early clinical uptake in selected indications, while robust academic networks have driven multicenter evidence generation. Transitioning from early adopters to broader institutional adoption requires alignment between clinical champions and procurement decision-makers, and the regional reimbursement environment often determines the timing of that transition.

Europe, Middle East & Africa presents a more heterogeneous regulatory and reimbursement landscape, where national-level decision-making and varied healthcare delivery models require localized engagement strategies. In some jurisdictions, centralized health technology assessment processes raise the bar for evidence, while in others niche reimbursement pathways enable targeted deployment. Manufacturers must therefore calibrate clinical and economic dossiers to account for national differences in payer expectations and hospital financing.

Across Asia-Pacific, infrastructure investments and rising demand for minimally invasive treatments are creating sizable opportunities, yet market entry strategies must account for diverse regulatory regimes, varying imaging adoption and differing hospital procurement practices. In all regions, successful expansion hinges on demonstrating clear clinical value, operational fit and sustainable service models that match local healthcare priorities and resource constraints.

Competitive company intelligence on product pipelines, strategic partnerships, manufacturing scale, regulatory progress and go-to-market positioning

Company-level dynamics in the focused ultrasound sector are characterized by a blend of competition, collaboration and strategic specialization. Leading developers are pursuing dual strategies: advancing core technology capabilities while forming partnerships that expand clinical reach and service capacity. Investment focus commonly includes improving treatment planning software, enhancing imaging integration and reducing per-procedure complexity to lower training thresholds and expand usable settings. Manufacturing scale and quality systems are increasingly central to competitive positioning, particularly as devices move from early clinical use into routine hospital operations.

Strategic alliances with academic centers and clinical networks remain a critical tactic for accelerating evidence generation and establishing centers of excellence. At the same time, commercial differentiation often hinges on service models that bundle training, maintenance and outcome support, addressing purchaser concerns about operational risk. Regulatory progress and clearances are leveraged to gain market access, but companies also emphasize post-market evidence collection and real-world data initiatives to support reimbursement conversations. For smaller innovators, partnering with established distributors or device platforms is a pragmatic route to market, while larger firms pursue selective acquisitions to fill technology or geographic gaps. The competitive landscape will favor organizations that integrate clinical validation with scalable manufacturing and pragmatic commercialization models.

Strategic recommendations enabling industry leaders to accelerate clinical adoption, optimize supply chains, align reimbursement approaches and prioritize R&D

Industry leaders should concentrate on a set of actionable priorities that translate strategic intent into measurable outcomes. First, aligning R&D roadmaps with clinical workflows will ensure that device features reduce procedural complexity and address clinician pain points; investments in user-centered design and integrated imaging workflows typically yield faster institutional adoption. Second, strengthening supply chain resilience through supplier diversification, localized assembly and modular component strategies can mitigate tariff exposure and reduce lead-time volatility.

Third, evidence strategies should be tiered: focused, indication-specific clinical programs that demonstrate meaningful patient outcomes must be complemented by pragmatic real-world evidence initiatives to support reimbursement discussions. Fourth, commercial models need to be tailored by end-user; ambulatory surgical centers, hospitals and specialty clinics each require distinct pricing, training and service packages to align with purchasing behaviors. Finally, strategic partnerships with payers, academic collaborators and systems integrators can accelerate market access and broaden referral networks. Executives who operationalize these priorities-by setting clear metrics, allocating cross-functional resources and maintaining agile governance-will be better positioned to convert technological promise into durable clinical and commercial impact.

Rigorous research methodology describing primary and secondary data, expert interviews, validation steps, segmentation logic and analytical techniques

The research methodology underpinning this analysis adheres to rigorous primary and secondary evidence collection, expert validation and transparent segmentation logic. Primary research activities included structured interviews with clinical opinion leaders, procurement professionals and technology executives to capture frontline perspectives on clinical workflows, adoption barriers and purchasing priorities. Secondary research drew on peer-reviewed literature, regulatory clearances and public filings to triangulate clinical outcomes, device characteristics and pathway evolution.

Validation steps incorporated cross-checks between interview insights and published data, while analytical techniques combined qualitative thematic synthesis with structured segmentation frameworks to surface actionable conclusions. The segmentation logic maps imaging guidance options, delivery modes, technological categories, product form factors, clinical applications and end-user settings to observed adoption behaviors and operational constraints. Throughout the process, quality controls ensured that assumptions were documented, sources were traceable and interpretations were anchored to empirical evidence.

This methodological approach balances depth of clinical insight with operational rigor to provide stakeholders a dependable foundation for strategic decisions and follow-on analysis.

Conclusion synthesizing strategic takeaways, emergent risks and opportunities, and actions leaders should pursue to navigate the focused ultrasound landscape

In synthesis, the high intensity focused ultrasound landscape presents a compelling mix of clinical promise and operational complexity that requires disciplined strategic action. Key takeaways emphasize the importance of aligning device capabilities with clinical workflows, demonstrating clear patient-centered outcomes and packaging value in ways that are meaningful to procurement and reimbursement stakeholders. Emergent risks include supply chain disruptions, regulatory variability across jurisdictions and the need for robust evidence to unlock wider payer support.

Opportunities are concentrated where technology attributes reduce procedural burden, expand the settings of care and provide measurable improvements in patient experience or health-system efficiency. Organizations that can integrate clinical validation, scalable manufacturing and pragmatic commercialization will capture the most durable advantage. Leaders should adopt a proactive posture-investing in supply chain resilience, tailoring go-to-market models by end-user setting, and cultivating payer and clinical partnerships that support broader adoption.

Ultimately, clear strategic focus, evidence-aligned execution and operational adaptability will determine which stakeholders successfully convert innovation into sustained clinical and commercial impact in this evolving therapeutic area.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. High Intensity Focused Ultrasound Devices Market, by Guidance

  • 8.1. MRI Guided
  • 8.2. Ultrasound Guided

9. High Intensity Focused Ultrasound Devices Market, by Delivery Mode

  • 9.1. Extracorporeal
  • 9.2. Interstitial
  • 9.3. Intracavitary

10. High Intensity Focused Ultrasound Devices Market, by Technology

  • 10.1. Mechanical Ablation
  • 10.2. Thermal Ablation
    • 10.2.1. Continuous Wave
    • 10.2.2. Pulsed Wave

11. High Intensity Focused Ultrasound Devices Market, by Product

  • 11.1. Portable
  • 11.2. Stationary

12. High Intensity Focused Ultrasound Devices Market, by Application

  • 12.1. Liver Tumor
  • 12.2. Pancreatic Tumor
  • 12.3. Prostate Cancer
  • 12.4. Uterine Fibroids

13. High Intensity Focused Ultrasound Devices Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Hospitals
  • 13.3. Specialty Clinics

14. High Intensity Focused Ultrasound Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. High Intensity Focused Ultrasound Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. High Intensity Focused Ultrasound Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States High Intensity Focused Ultrasound Devices Market

18. China High Intensity Focused Ultrasound Devices Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Alpinion Medical Systems Co., Ltd.
  • 19.6. Chongqing Haifu Medical Technology Co., Ltd.
  • 19.7. EDAP TMS S.A.
  • 19.8. FEBIO GmbH
  • 19.9. FUS Instruments Inc.
  • 19.10. ILJIN Holdings Co., Ltd.
  • 19.11. Image Guided Therapy SAS
  • 19.12. Insightec Ltd.
  • 19.13. Mianyang Sonic Electronic Ltd.
  • 19.14. Profound Medical Corp.
  • 19.15. Shenzhen Weixianke Electronics Co., Ltd.
  • 19.16. SonaCare Medical LLC
  • 19.17. Storz Medical AG
  • 19.18. Theraclion

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 140. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 142. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 143. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 164. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 166. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 167. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 171. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 172. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 174. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 175. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)